Publication dates

Drug Development Industry, October 2014 Market Reports from Top Publishers

You might be interested in: Drug, Cancer, Therapeutics, more »


 
1-10 of about 900 reports for Drug Development

Bioanalytical Systems, Inc. (Symbol:BASI) SWOT Analysis, Strategy, Revenues and Profits

Bioanalytical Systems, Inc. (Symbol:BASI) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Bioanalytical systems's services include drug discovery services, drug development services, and generic drug development services. The company offers drug development services such as preclinical toxicology ...

FASgen, Inc. SWOT Analysis, Strategy, Revenues and Profits

FASgen, Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Fasgen, inc. - Strategic swot analysis review summaryfasgen, inc. (Fasgen) is a drug development company. Fasgen manufactures and develops drugs and therapeutic products based ...

Southern Research Institute SWOT Analysis, Strategy, Revenues and Profits

Southern Research Institute SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... And applied research in the areas of advanced engineering, preclinical drug development, drug discovery and environmental protection. It offers services to life sciences, energy, engineering and environmental ...

JCL Bioassay Corporation (Symbol:2190) SWOT Analysis, Strategy, Revenues and Profits

JCL Bioassay Corporation (Symbol:2190) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Jcl bioassay corporation (2190) - financial and strategic swot analysis review summaryjcl bioassay corporation (jcl) is a contract research organization. The organization offers drug ...

MIGENIX Inc. (BWESF) - Strategic SWOT Analysis Review

MIGENIX Inc. (BWESF) - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Its drug development programs that two phase iii studies for the prevention of catheter-related infections. The company is headquartered in vancouver, canada.This comprehensive swot profile ...

Changchun High-tech Industrial (Group) Co., Ltd. (000661) - Financial and Strategic SWOT Analysis Review

Changchun High-tech Industrial (Group) Co., Ltd. (000661) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Estate. Its pharmaceutical products include biological vaccine and genetics engineering medicine. The services offered by changchun include drug development, technology transfer, technical advisory ...

Venturepharm Laboratories Limited - Strategic SWOT Analysis Review

Venturepharm Laboratories Limited - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Venturepharm laboratories limited - strategic swot analysis review summaryventurepharm laboratories limited (venturepharm) is a drug development company. The company provides research ...

Alzheimer's Disease Drug Pipeline, Diagnostics and Biomarkers:  New Developments, Growth Areas and Opportunities

Alzheimer's Disease Drug Pipeline, Diagnostics and Biomarkers: New Developments, Growth Areas and Opportunities

  • $ 3 170
  • Industry report
  • September 2014
  • by BioPharm Reports

... A comprehensive and up-to-date review of the current ad drug development pipeline by company, developmental phase (phase 3 to preclinical), pharmacological targeting mechanisms and other areas. ...

Nanoparticles in Biotechnology, Drug Development and Drug Delivery

Nanoparticles in Biotechnology, Drug Development and Drug Delivery

  • $ 6 650
  • Industry report
  • August 2014
  • by BCC Research

... Of 23.0% For the period of 2014 to 2019. - drug development and formulation as a segment is projected to increase from nearly $12.6 Billion in 2014 to $32.3 Billion by 2019, with a cagr of 20 ...

Piramal Life Sciences Limited (PIRLIFE) - Financial and Strategic SWOT Analysis Review

Piramal Life Sciences Limited (PIRLIFE) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • August 2014
  • by Global Data

... The company is principally engaged in the drug discovery and drug development in four therapeutic areas, namely, cancer, diabetes, inflammation and infectious diseases. The company has 13 products in its ...

About 2 600 reports for Drug Development

Download Unlimited Documents from Trusted Public Sources

Medicine Markets in the US

  • Full Color
  • January 2013
    78 pages
  • Medicine  

  • United States  

View report >

Annual Report 2013

January 2013

1 Companies for Drug Development

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.